PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

ACG Capsules introduces ACGcaps™ H+ a new line of Clean Label, Inert and Robust HPMC Capsules

ACG Capsules (ACGC) – part of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry – has introduced a new line of HPMC capsules meeting a wide variety of pharmaceutical and nutraceutical needs. The new ACGcaps™ H+ capsule with no gelling agent is suitable for hygroscopic and moisture-sensitive formulations. It also meets consumer demands for clean label and vegetarian capsule options. 

ACGcaps™ H+ Capsule complies with requirements of dissolution performance across all biological pH range since it is pH-independent and non-ionic. These capsules also reduce cross-linking problems which occur with gelatin base capsules resulting in retarded dissolution performance. 

ACGcaps™ H+ capsules are suitable for filling granules, powders, pellets for prescription and non-prescription pharmaceutical ingredients, nutraceutical dietary supplements and traditional medicines. 

“The new and enhanced range of HPMC capsules are designed to give pharma and nutraceutical customers added peace of mind by providing product protection and desired formulation release. The new line contains no gelatin, wheat, gluten, animal by-products or starch, making them ideal for supporting clean label claims and vegetarian diets.”, said Selwyn Noronha, CEO for ACG Capsules.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026